Skip to main content
. 2020 Dec 30;15(12):e0244183. doi: 10.1371/journal.pone.0244183

Fig 5. VA outcomes at 1 year in patients who received prior ranibizumab treatment for <1 year: Stratified by injection frequency.

Fig 5

n, number of patients with evaluable patients with baseline and Month 12 data; ETDRS, Early Treatment Diabetic Retinopathy Study; VA, visual acuity.